Alcobra Ltd. (ADHD) was a big mover last session, as the company saw its shares rise by roughly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now over 27% in the past one-month time frame.
This drug manufacturer has seen one negative estimate revision over the past 30 days and its Zacks Consensus Estimate has moved down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.
Alcobra currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include Biomerica Inc. (BMRA), POZEN Inc. (POZN) and Ariad Pharmaceuticals Inc. (ARIA). While Biomerica and POZEN hold a Zacks Rank #1 (Strong Buy), Ariad Pharmaceuticals carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALCOBRA LTD ORD (ADHD): Free Stock Analysis Report
BIOMERICA INC (BMRA): Free Stock Analysis Report
POZEN INC (POZN): Free Stock Analysis Report
ARIAD PHARMACEUTICALS INC (ARIA): Free Stock Analysis Report
Zacks Investment Research